BMO Capital Starts Pacira Pharmaceuticals (PCRX) at Underperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
| PACIRA (NASDAQ: PCRX) | Delayed: 25.20 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.20 | 52 Week High | $80.25 | |||
| Open | $25.20 | 52 Week Low | $30.25 | |||
| Day High | $25.20 | P/E | N/A | |||
| Day Low | $25.20 | EPS | $-2.08 | |||
| Volume | 1,752 | |||||
